Tot Biopharm International Co

Tot Biopharm International Co's reported carbon emissions

Tot Biopharm International Co., a pharmaceutical preparation manufacturer based in China, has disclosed its carbon emissions data for the years 2019 to 2022. In 2022, the company reported Scope 1 and Scope 2 emissions totalling approximately 11,431,000 kg CO2e. This figure is comprised of Scope 1 emissions of about 4,516,000 kg CO2e and Scope 2 emissions of approximately 6,915,000 kg CO2e. For the preceding years, Tot Biopharm International Co. reported the following Scope 1 and 2 emissions: * **2021:** Approximately 15,014,000 kg CO2e (Scope 1: 4,722,000 kg CO2e, Scope 2: 10,291,000 kg CO2e). * **2020:** Approximately 14,769,000 kg CO2e (Scope 1: 5,075,000 kg CO2e, Scope 2: 9,693,000 kg CO2e). * **2019:** Approximately 11,319,000 kg CO2e (Scope 1: 3,562,000 kg CO2e, Scope 2: 7,757,000 kg CO2e). There is no disclosed Scope 3 emissions data for Tot Biopharm International Co. for the reporting years provided. The company's most recent disclosure is from 2023, where no emissions data was reported. Tot Biopharm International Co. has not publicly announced any specific greenhouse gas reduction targets or commitments, such as those aligned with the Science Based Targets initiative (SBTi) or the Climate Pledge.